CG
Column Group Portfolio holdings
AUM
$65.7M
This Quarter Return
-8.63%
1 Year Return
-5.8%
3 Year Return
-15.66%
5 Year Return
–
10 Year Return
–
AUM
$707M
AUM Growth
+$707M
(-32%)
Cap. Flow
-$175M
Cap. Flow
% of AUM
-24.74%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Nurix Therapeutics
NRIX
|
$167M |
| 2 |
Revolution Medicines
RVMD
|
$7.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $304M | 42.97% | 15,396,116 | – | – |
|
2
RAPT Therapeutics
RAPT
$188M
| $124M | 17.48% | 3,885,679 | – | – |
|
|
3
Revolution Medicines
RVMD
$7.1B
| $106M | 15.04% | 3,347,245 -233,007 | -7% | -$7.4M |
|
|
CNST
4
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $88.8M | 12.57% | 2,626,631 | – | – |
|
5
Oric Pharmaceuticals
ORIC
$994M
| $84.3M | 11.94% | 4,768,181 | – | – |
|
|
6
Nurix Therapeutics
NRIX
$714M
| – | – | -5,383,333 | Closed | -$167M |
|